US Stock Market Move | Some countries are experiencing an upward trend in new cases of COVID-19. Moderna stock (MRNA.US) has risen by over 10%.

On Tuesday, Moderna's stock price (MRNA.US) rose, with the stock up over 10% to $29.265 as of the press release. The vaccine sector as a whole saw gains, with Novavax, Inc. (NVAX.US) up over 2% to $7.92, and Pfizer Inc. (PFE.US) up 2% to $23.46. In terms of news, according to the World Health Organization, there is a recent upward trend in the COVID-19 outbreak in countries in West Africa, Central America and the Caribbean, Eastern Europe, Southwest Europe, and Western Asia.